283 related articles for article (PubMed ID: 38671465)
1. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.
Mahboobipour AA; Ala M; Safdari Lord J; Yaghoobi A
Orphanet J Rare Dis; 2024 Apr; 19(1):175. PubMed ID: 38671465
[TBL] [Abstract][Full Text] [Related]
2. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease.
Masyuk T; Masyuk A; Trussoni C; Howard B; Ding J; Huang B; LaRusso N
JHEP Rep; 2021 Oct; 3(5):100345. PubMed ID: 34568801
[TBL] [Abstract][Full Text] [Related]
3. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Porath B; Gainullin VG; Cornec-Le Gall E; Dillinger EK; Heyer CM; Hopp K; Edwards ME; Madsen CD; Mauritz SR; Banks CJ; Baheti S; Reddy B; Herrero JI; Bañales JM; Hogan MC; Tasic V; Watnick TJ; Chapman AB; Vigneau C; Lavainne F; Audrézet MP; Ferec C; Le Meur Y; Torres VE; ; ; Harris PC
Am J Hum Genet; 2016 Jun; 98(6):1193-1207. PubMed ID: 27259053
[TBL] [Abstract][Full Text] [Related]
4. Genetics and mechanisms of hepatic cystogenesis.
van de Laarschot LFM; Drenth JPH
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1491-1497. PubMed ID: 28782656
[TBL] [Abstract][Full Text] [Related]
5. Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis.
Sierks D; Schönauer R; Friedrich A; Hantmann E; de Fallois J; Linder N; Fischer J; Herber A; Bergmann C; Berg T; Halbritter J
JHEP Rep; 2022 Nov; 4(11):100579. PubMed ID: 36246085
[TBL] [Abstract][Full Text] [Related]
6. Genetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes.
Yang H; Sieben CJ; Schauer RS; Harris PC
Adv Kidney Dis Health; 2023 Sep; 30(5):397-406. PubMed ID: 38097330
[TBL] [Abstract][Full Text] [Related]
7. Cilia and polycystic kidney disease.
Ma M
Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
[TBL] [Abstract][Full Text] [Related]
8. Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.
Wills ES; Te Morsche RHM; van Reeuwijk J; Horn N; Geomini I; van de Laarschot LFM; Mans DA; Ueffing M; Boldt K; Drenth JPH; Roepman R
Hum Mol Genet; 2017 Nov; 26(21):4190-4202. PubMed ID: 28973524
[TBL] [Abstract][Full Text] [Related]
9. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.
Lanktree MB; Haghighi A; Guiard E; Iliuta IA; Song X; Harris PC; Paterson AD; Pei Y
J Am Soc Nephrol; 2018 Oct; 29(10):2593-2600. PubMed ID: 30135240
[TBL] [Abstract][Full Text] [Related]
10. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.
Cnossen WR; Drenth JP
Orphanet J Rare Dis; 2014 May; 9():69. PubMed ID: 24886261
[TBL] [Abstract][Full Text] [Related]
11. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
Cornec-Le Gall E; Torres VE; Harris PC
J Am Soc Nephrol; 2018 Jan; 29(1):13-23. PubMed ID: 29038287
[TBL] [Abstract][Full Text] [Related]
12. Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry.
Delbarba E; Econimo L; Dordoni C; Martin E; Mazza C; Savoldi G; Alberici F; Scolari F; Izzi C
J Nephrol; 2022 Mar; 35(2):645-652. PubMed ID: 34357571
[TBL] [Abstract][Full Text] [Related]
13. Genetic Analysis of Severe Polycystic Liver Disease in Japan.
Mizuno H; Besse W; Sekine A; Long KT; Kurihara S; Oba Y; Yamanouchi M; Hasegawa E; Suwabe T; Sawa N; Ubara Y; Somlo S; Hoshino J
Kidney360; 2024 May; ():. PubMed ID: 38689396
[TBL] [Abstract][Full Text] [Related]
14. Polycystic Liver Disease: Advances in Understanding and Treatment.
Masyuk TV; Masyuk AI; LaRusso NF
Annu Rev Pathol; 2022 Jan; 17():251-269. PubMed ID: 34724412
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Targets in Polycystic Liver Disease.
Masyuk TV; Masyuk AI; LaRusso NF
Curr Drug Targets; 2017; 18(8):950-957. PubMed ID: 25915482
[TBL] [Abstract][Full Text] [Related]
16. Genetics of polycystic liver diseases.
Lee-Law PY; van de Laarschot LFM; Banales JM; Drenth JPH
Curr Opin Gastroenterol; 2019 Mar; 35(2):65-72. PubMed ID: 30652979
[TBL] [Abstract][Full Text] [Related]
17. Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease.
Boerrigter MM; Duijzer R; Te Morsche RHM; Drenth JPH
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761895
[TBL] [Abstract][Full Text] [Related]
18.
Besse W; Chang AR; Luo JZ; Triffo WJ; Moore BS; Gulati A; Hartzel DN; Mane S; ; Torres VE; Somlo S; Mirshahi T
J Am Soc Nephrol; 2019 Nov; 30(11):2091-2102. PubMed ID: 31395617
[TBL] [Abstract][Full Text] [Related]
19. New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease.
Barten TRM; Bernts LHP; Drenth JPH; Gevers TJG
Expert Opin Ther Targets; 2020 Jun; 24(6):589-599. PubMed ID: 32250187
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]